Should you hold Aphria (APHA) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares. View analyst ratings for Aphria or view top-rated stocks.
What happened to Aphria shares?
Aphria has stopped trading and all Aphria shares are now converted to Tilray shares. The merger had got delayed due to the delay in approval from Tilray shareholders.
When do APHA earnings call for 2019?
APHA earnings call for the period ending November 30, 2019. APHA earnings call for the period ending August 31, 2019. APHA earnings call for the period ending June 30, 2019. APHA earnings call for the period ending February 28, 2019. Primary metrics and data points about Aphria Inc..
Will APHA outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe APHA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
What will happen to APHA stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
Why did APHA stock drop?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.
What happen to APHA?
Aphria's (NASDAQ:APHA) last trading day is today after it complete its deal with Tilray (NASDAQ:TLRY). The effective date for suspension of the shares is Monday, according to a Nasdaq delisting notice.
Is Aphria a good stock to buy now?
Currently, Aphria is trading at close to 0.73 times Tilray's share price. The single most compelling reason to buy Aphria stock right now is that this ratio absolutely must increase to the 0.8381 ratio included in the merger agreement.
Should I sell my Aphria stock?
Aphria Inc(APHA-T) Rating Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
Did Tilray buy Aphria?
Tilray-Aphria merger closes, expanded company to control biggest share of Canadian pot market. Canadian cannabis companies Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.
Why is Aphria delisted?
“In the past, Aphria had substantial holdings in the U.S. But the company was forced by TMX, the operator of the Toronto Stock Exchange, to divest those holdings because, while pot remains illegal under U.S. federal law, it ran the risk of having its stock delisted.” Aphria is listed on the NYSE (NYSE: APHA).
Is APHA delisted?
End of APHA stock, you say? Well, it is being delisted. But shareholders, who voted an astonishing 99.38% in favor of the merger, got 0.8381 of a share of TLRY stock for each of their Aphria shares. That's 0.8381 of a share of stock in what is now the largest cannabis company by revenue.
How much did Tilray buy Aphria for?
Back in December, Tilray entered into a definitive agreement to acquire Aphria in a deal with a listed market valuation of ~$4 billion, at the time. Aphria shareholders will receive 0.8381 shares of Tilray and end up controlling 62% of the company.
Is APHA now Tilray?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.
Will Tilray ever recover?
In his interview with New Cannabis Ventures, CEO Simon Irwin said that Tilray could generate $4bn of sales in Europe by the end of 2024.
Is Tilray a good buy now?
Investors who can wait for Tilray to reap the benefits of the Aphria merger and the strategic deal with Hexo can buy the stock on the dip now to hold it for the long haul. Analysts see an average upside of 163% for this pot stock for the next 12 months. This may be the only Canadian pot stock to invest in right now.
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quart...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Tilray (TLRY) , Canopy Growth (CGC) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria (NASDAQ:APHA) has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 mil...
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
What is Aphria's official website?
The official website for Aphria is aphriainc.com .
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $6.54M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include Valeant Pharmaceuticals International (VRX) , Evotec (EVT) , Bausch Health Companies (BHC) ,...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB) , Cano...
What is Aphria's stock symbol?
Aphria trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."
How do I buy shares of Aphria?
Shares of APHA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadia...
How much money does Aphria make?
Aphria (TSE:APHA) has a market capitalization of C$0.00 and generates C$611.06 million in revenue each year.
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
What is Aphria's official website?
The official website for Aphria is www.aphria.com .
How can I contact Aphria?
Aphria's mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada . The company can be reached via phone at 844-427-4742 .
How many hold ratings are there for Aphria?
There are currently 5 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares.
Is Aphria a hold stock?
Wall Street analysts have given Aphria a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Aphria wasn't one of them.
About Aphria
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands.
Headlines
Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table - Benzinga - Benzinga
Aphria (TSE:APHA) Frequently Asked Questions
4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Aphria stock.
Why are Analyst Ratings Important?
Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover.
What's Happening With Aphria Inc Stock Today?
Aphria Inc (APHA) stock is trading at $3.64 as of 9:31 AM on Tuesday, May 19, a rise of $0.06, or 1.68% from the previous closing price of $3.58. The stock has traded between $3.61 and $3.66 so far today. Volume today is light. So far 103,703 shares have traded compared to average volume of 7,003,986 shares.
When did Aphria go public?
Shares of Aphria (TSX:APHA) (NASDAQ:APHA) were trading at $0.75 shortly after it went public in December 2014.
How much is Aphria sales in 2021?
In the fiscal third quarter of 2021, Aphria reported net sales of $153.6 million. This reflected a year-over-year increase of 6.4% compared to net sales of $144.4 million in the prior-year period. Comparatively, Bay Street expected Aphria to post sales of $166.2 million in the December quarter.
Is Aphria a Tilray?
The most important driver of Aphria stock is its upcoming merger with Tilray, which will make the combined entity the largest cannabis company in the world. Both the companies already have a presence in the U.S. and can scale production once marijuana is legalized in the country.
